Form 4 Filing for AETHLON MEDICAL INC

This filing details a transaction by Shah Chetan, a director at AETHLON MEDICAL INC (AEMD). On April 17, 2026, Shah Chetan acquired 21,815 shares of Common Stock at a price of $2.29 per share. This acquisition was part of a grant of Restricted Stock Units (RSUs) that vest in four equal quarterly installments through March 31, 2027, contingent upon continued service. Following this transaction, Shah Chetan holds a total of 23,021 shares. The transaction is reported on Form 4, and the details are documented with a signature date of April 21, 2026.